Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody Fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein

Virology

Volumn 252, Issue 2, 1998, Pages 373-375

  Crowe Jr , James E ^a   Firestone, Cai Yen ^a   Crim, Roberta ^a   Beeler, Judy A ^a   Coelingh, Kathleen L ^a   Barbas III, Carlos F ^b   Burton, Dennis R ^b   Chanock, Robert M ^a   Murphy, Brian R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; BINDING SITE; DRUG RECEPTOR BINDING; IMMUNOPROPHYLAXIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEQUENCE ANALYSIS; VIRUS INFECTION; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS RESISTANCE;

ANIMALIA; DNA VIRUSES; MURINAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SYNCYTIAL VIRUS;

EID: 0032567517     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9462     Document Type: Article

References (10)

1. Arbiza J., Taylor G., Lopez J. A., Furze J., Wyld S., Whyte P., Stott E. J., Wertz G., Sullender W., Trudel M. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 73:1992;2225-2234.
2. Barbas C. F., Crowe J. E. Jr., Cababa D., Jones T. M., Zebedee S. L., Murphy B. R., Chanock R. M., Burton D. R. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc. Natl. Acad. Sci. USA. 89:1992;10164-10168.
3. Beeler J. A., van Wyke Coelingh K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: Effect of mutation upon fusion function. J. Virol. 63:1989;2941-2950.
4. Collins P. L., McIntosh K., Chanock R. M. Field's Virology. 1996;Lippincott-Raven Press, New York. p. 1313-1351.
5. Connors M., Crowe J. E. Jr., Firestone C. Y., Murphy B. R., Collins P. L. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. Virology. 208:1995;478-484.
6. Crowe J. E. Jr., Murphy B. R., Chanock R. M., Williamson R. A., Barbas C. F. III, Burton D. R. Recombinant human RSV monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of respiratory syncytial virus-infected mice. Proc. Natl. Acad. Sci. USA. 91:1994;1386-1390.
7. Groothuis J. R., Simoes E. A., Levin M. J., Hall C. B., Long C. E., Rodriguez W. J., Arrobio J., Meissner H. C., Fulton D. R., Welliver R. C. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children: The Respiratory Syncytial Virus Immune Globulin Study Group. N. Engl. J. Med. 329:1993;1524-1530.
8. Hemming V. G., Prince G. A., Horswood R. L., London W. J., Murphy B. R., Walsh E. E., Fischer G. W., Weisman L. E., Baron P. A., Chanock R. M. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J. Infect. Dis. 152:1985;1083-1087.
9. Prince G. A., Hemming V. G., Horswood R. L., Chanock R. M. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 3:1985;193-206.
10. Walsh E. E., Schlesinger J. J., Brandriss M. W. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect. Immunol. 43:1984;756-758.